Literature DB >> 11819246

Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas.

Dan Luo, Qi-Fu Liu, C Gove, NV Naomov, Jian-Jia Su, R Williams.   

Abstract

AIM:To study the relationship between N-ras gene mutation and p53 gene expression in the carcinogenesis and the development of human hepatocellular carcinomas (HCC).
METHODS: The N-ras gene mutation and the p53 gene expression were analyzed in 29 cases of HCC by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and immunohistochemistry.
RESULTS: Thirteen cases of HCCs were p53 positive (44.8%), which showed a rather high Cpercen-tage of p53 gene mutation in Guangxi. The aberrations at N-ras codon 2-37 were found in 79.31% of HCCs and 80.77% of adjacent non-tumorous liver tissues. More than 2 point mutations of N-ras gene were observed in 22 cases (75.86%). Twelve cases (41.37%) of HCCs showed both N-ras gene mutation and p53 gene expression.
CONCLUSION: N-ras gene and p53 gene may be involved in the carcinogenesis and the development of HCC.That 38% of HCCs with N-ras gene mutation did not express p53 protein indicates that some other genes or factors may participate in the carcinogenesis and the development of HCC.

Entities:  

Year:  1998        PMID: 11819246      PMCID: PMC4688651          DOI: 10.3748/wjg.v4.i2.97

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

1.  Cancer genes. Telling changes of base.

Authors:  A L Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

2.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.

Authors:  P Hinds; C Finlay; A J Levine
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

Authors:  B Bressac; M Kew; J Wands; M Ozturk
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

4.  Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.

Authors:  B L Slagle; Y Z Zhou; J S Butel
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

5.  Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.

Authors:  M Tada; M Omata; M Ohto
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

6.  Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks.

Authors:  M Leon; M C Kew
Journal:  Anticancer Res       Date:  1995 May-Jun       Impact factor: 2.480

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines.

Authors:  M Farshid; E Tabor
Journal:  J Med Virol       Date:  1992-12       Impact factor: 2.327

  8 in total
  21 in total

1.  Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology.

Authors:  J Cui; D H Yang; X J Bi; Z R Fan
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma.

Authors:  Bert H O'Neil; Laura W Goff; John Sae Wook Kauh; Jonathan R Strosberg; Tanios S Bekaii-Saab; Ruey-Min Lee; Aslamuzzaman Kazi; Dominic T Moore; Maria Learoyd; Richard M Lush; Said M Sebti; Daniel M Sullivan
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

3.  Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma.

Authors:  Xue-Nong Li; Yan-Qing Ding; Guo-Bing Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

4.  Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.

Authors:  Xin-Rong Liu; Rou-Li Zhou; Qing-Yun Zhang; Ye Zhang; Yue-Ying Jin; Ming Lin; Jing-An Rui; Da-Xiong Ye
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

5.  KAI1 gene is differently expressed in papillary and pancreatic cancer: influence on metastasis.

Authors:  Xiao-Zhong Guo; Helmut Friess; Xiao-Dong Shao; Min-Pei Liu; Yu-Ting Xia; Jian-Hua Xu; Markus W Buchler
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

6.  Chemoprevention of tea on colorectal cancer induced by dimethylhydrazine in Wistar rats.

Authors:  Xu-Dong Jia; Chi Han
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

7.  Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.

Authors:  S J Moghaddam; E N Haghighi; S Samiee; N Shahid; A R Keramati; S Dadgar; M R Zali
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

8.  Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection.

Authors:  Q Wang; Z Y Lin; X L Feng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

9.  Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines.

Authors:  Miao-Wang Hao; Ying-Rui Liang; Yan-Fang Liu; Li Liu; Ming-Yao Wu; Huan-Xing Yang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

10.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.